Internal Medicine · Burbank, CA
NPI
1871723676
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
303 S Glenoaks Blvd, # 1
Burbank, CA, 91502
Phone (818) 331-7687
Groups this clinician bills Medicare through
Medicare paid, 2024
$464K
9,425 services
Medicare patients, 2024
509
Average age 74
Drug cost, 2024
$3.1M
22,245 prescriptions
Company payments, 2025
$206
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edmond Melikterminas was code 99214 (office e&m - established), 1,308 times for 271 patients. In total Edmond Melikterminas billed 9,425 services in 59 codes, and Medicare paid $464K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,308 | 271 | $108.52 | $142K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,128 | 111 | $0.79 | $886 |
| 82962 Clinical Chemistry | Office | 954 | 141 | $3.21 | $3,062 |
| 99213 Office E&M - Established | Office | 914 | 236 | $76.98 | $70K |
| 99457 E&M - Miscellaneous | Office | 894 | 95 | $42.42 | $38K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 823 | 76 | $53.24 | $44K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 476 | 93 | $26.77 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 395 | 118 | $64.69 | $26K |
| 36415 Venipuncture Blood Collection | Office | 379 | 220 | $5.88 | $2,229 |
| 99454 E&M - Miscellaneous | Office | 350 | 71 | $43.78 | $15K |
| 99308 SNF E&M | Facility | 296 | 48 | $61.88 | $18K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 244 | 244 | $26.85 | $6,552 |
| 93000 Electrocardiogram | Office | 123 | 96 | $12.42 | $1,528 |
| 99291 Critical Care E&M | Facility | 103 | 16 | $172.47 | $18K |
| 20605 Joint Injection | Office | 73 | 53 | $49.29 | $3,598 |
By year: 2022 $375K for 7,057 services; 2023 $406K for 7,801 services; 2024 $464K for 9,425 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 954 | 141 | $3.21 | $3,062 |
| 36415 Venipuncture Blood Collection | 379 | 220 | $5.88 | $2,229 |
| 81002 Clinical Chemistry | 44 | 32 | $3.41 | $150 |
Medicare prescription drug claims, 2024
In 2024, the drug Edmond Melikterminas prescribed most often to Medicare patients was Rosuvastatin Calcium, with 862 prescriptions and refills. In total Edmond Melikterminas wrote 22,245 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 862 | 1,142 | 121 | $4,050 |
| Pantoprazole Sodium Generic | 650 | 724 | 118 | $3,804 |
| Amlodipine Besylate Generic | 596 | 812 | 104 | $1,959 |
| Atorvastatin Calcium Generic | 565 | 820 | 99 | $3,042 |
| Gabapentin Generic | 547 | 577 | 99 | $1,996 |
| Metoprolol Succinate Generic | 506 | 712 | 81 | $2,937 |
| Levothyroxine Sodium Generic | 479 | 642 | 66 | $2,989 |
| Linzess Linaclotide | 444 | 477 | 82 | $249K |
| Metformin Hcl Generic | 407 | 552 | 68 | $1,172 |
| Ezetimibe Generic | 375 | 466 | 56 | $3,461 |
| Diclofenac Sodium Generic | 371 | 384 | 92 | $112K |
| Tamsulosin Hcl Generic | 367 | 445 | 63 | $2,028 |
| Losartan Potassium Generic | 363 | 472 | 74 | $1,964 |
| Jardiance Empagliflozin | 301 | 395 | 43 | $232K |
| Famotidine Generic | 288 | 316 | 55 | $3,612 |
Brand drugs: 4,362 claims; generic drugs: 17,610 claims; opioid claims: 61.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edmond Melikterminas $206 ($206 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $175.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.